Australian Prescriber Podcast E179 - Therapeutic vapes for smoking cessation and nicotine dependence
18 snips
Jan 6, 2025 Eileen Cole, GP lead at QUIT, and Jennifer Kyi, pharmacist advisor at QUIT, delve into the emerging role of therapeutic vapes in smoking cessation. They discuss upcoming legislative reforms in Australia that will impact the sale of vapes, set to start in July 2024. The conversation highlights current trends in smoking and vaping, the updated guidelines for health professionals, and the complexities of prescribing vaping products. They emphasize the importance of personalized strategies for effective cessation and the crucial role of pharmacists in this landscape.
AI Snips
Chapters
Transcript
Episode notes
First-Line Smoking Cessation
- First-line smoking cessation options include nicotine replacement therapy (NRT) and oral medications like varenicline and bupropion.
- Combine short- and long-acting NRT formulations for best results, available over the counter.
Assessing Nicotine Dependence
- Assess nicotine dependence by asking about time to first cigarette and daily cigarette count.
- Patients smoking within 30 minutes of waking and over 10 cigarettes daily may have nicotine dependence.
Vaping for Smoking Cessation
- Vaping is not a first-line treatment and has unknown long-term health effects.
- Use vapes for a maximum of 12 months with shared decision-making and patient awareness of the risks.